Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system. (Q50499408)

14 March 2018

title

Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system. (English)

1 reference

14 March 2018

1 reference

4

Peter Nygren

1 reference

14 March 2018

3

Rolf Larsson

1 reference

14 March 2018

2

Mårten Fryknäs

1 reference

14 March 2018

author name string

Henning Karlsson

series ordinal

1

1 reference

14 March 2018

language of work or name

English

0 references

publication date

2 April 2012

1 reference

14 March 2018

Experimental Cell Research

published in

1 reference

14 March 2018

volume

318

1 reference

14 March 2018

issue

13

1 reference

14 March 2018

page(s)

1577-1585

1 reference

14 March 2018

Anticancer drug discovery and development.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

The fluorometric microculture cytotoxicity assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Human tumor cloning assays: applications in clinical oncology and new antineoplastic agent development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Timeline: Chemotherapy and the war on cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Antineoplastic drug screening belongs in the laboratory, not in the clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Predictive tests for individualization of pharmacological cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

The use of 3-D cultures for high-throughput screening: the multicellular spheroid model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Multicellular spheroids. A review on cellular aggregates in cancer research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Three-dimensional in vitro tissue culture models of breast cancer-- a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Integrin signalling during tumour progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Cell signaling by receptor tyrosine kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Cetuximab for the treatment of colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Novel activity of acriflavine against colorectal cancer tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

In vitro determination of cytotoxic drug response in ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Overview of the clinical efficacy of investigational anticancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

In vitro chemosensitivity testing and mechanisms of drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Detection of a decrease in green fluorescent protein fluorescence for the monitoring of cell death: an assay amenable to high-throughput screening technologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

Recent advancements on the identification of immature cancer cells with the stem cell-like properties in different aggressive and recurrent cancer types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.026

10.1016/J.YEXCR.2012.03.026

7 January 2021

Identifiers

DOI

1 reference

14 March 2018

PubMed ID

22487097

1 reference

14 March 2018